IS2488B - Fyrirbygging á krabbameini í ristli og endaþarmi - Google Patents

Fyrirbygging á krabbameini í ristli og endaþarmi

Info

Publication number
IS2488B
IS2488B IS6317A IS6317A IS2488B IS 2488 B IS2488 B IS 2488B IS 6317 A IS6317 A IS 6317A IS 6317 A IS6317 A IS 6317A IS 2488 B IS2488 B IS 2488B
Authority
IS
Iceland
Prior art keywords
cancer
prevention
prostate
bladder
lung
Prior art date
Application number
IS6317A
Other languages
English (en)
Other versions
IS6317A (is
Inventor
Henrik Raskov Hans
Original Assignee
Colotech A/S
Henrik Raskov Hans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colotech A/S, Henrik Raskov Hans filed Critical Colotech A/S
Publication of IS6317A publication Critical patent/IS6317A/is
Publication of IS2488B publication Critical patent/IS2488B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS6317A 1999-09-29 2002-03-20 Fyrirbygging á krabbameini í ristli og endaþarmi IS2488B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901390 1999-09-29
PCT/DK2000/000546 WO2001022974A1 (en) 1999-09-29 2000-09-29 Prevention of colorectal cancer

Publications (2)

Publication Number Publication Date
IS6317A IS6317A (is) 2002-03-20
IS2488B true IS2488B (is) 2008-12-15

Family

ID=8104340

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6317A IS2488B (is) 1999-09-29 2002-03-20 Fyrirbygging á krabbameini í ristli og endaþarmi

Country Status (13)

Country Link
US (1) US7851461B2 (is)
EP (1) EP1220676B1 (is)
AT (1) ATE294585T1 (is)
AU (1) AU779996B2 (is)
CA (1) CA2385755C (is)
DE (1) DE60019947T2 (is)
DK (1) DK1220676T3 (is)
ES (1) ES2240159T3 (is)
IS (1) IS2488B (is)
NO (1) NO330061B1 (is)
NZ (1) NZ517978A (is)
PT (1) PT1220676E (is)
WO (1) WO2001022974A1 (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
WO2002080889A2 (en) * 2001-04-05 2002-10-17 Colotech A/S A combination dosage of a cyclooxygenase (cox) inhibitor, a vitamin d3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
ATE294585T1 (de) 1999-09-29 2005-05-15 Colotech As Vorbeugung von kolorektalkrebs
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
WO2011024208A1 (en) * 2009-08-24 2011-03-03 Colotech A/S Combination dosage form with acetylsalicylic acid, calcitriol and calcium
WO2011079249A2 (en) * 2009-12-23 2011-06-30 Glycomyr, Inc. Use of vitamin d glycosides and sulfates for treatment of disease
WO2012116699A1 (en) 2011-02-28 2012-09-07 Rigshospitalet Copenhagen University Hospital Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205025A1 (en) 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorine derivatives of vitamin D3 and cell differentiation-inducing agents containing the same as an active ingredient
EP0412110B1 (en) 1988-04-21 1993-07-07 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
DK0614455T3 (da) 1991-11-07 1996-03-18 Res Inst Medicine Chem Vitamin D-amidderivater
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
DE4334154C2 (de) 1993-10-01 1997-05-22 Schering Ag 2-Halogeno-1,25-dihydroxy-cholecalciferole und pharmazeutische Zusammensetzungen
EP0833664A1 (en) 1995-06-12 1998-04-08 G.D. SEARLE & CO. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
ATE294585T1 (de) 1999-09-29 2005-05-15 Colotech As Vorbeugung von kolorektalkrebs

Also Published As

Publication number Publication date
US20040116393A1 (en) 2004-06-17
ES2240159T3 (es) 2005-10-16
DK1220676T3 (da) 2005-09-05
ATE294585T1 (de) 2005-05-15
CA2385755A1 (en) 2001-04-05
US7851461B2 (en) 2010-12-14
NZ517978A (en) 2003-11-28
NO20021437L (no) 2002-05-24
DE60019947T2 (de) 2006-02-02
AU7406300A (en) 2001-04-30
WO2001022974A1 (en) 2001-04-05
EP1220676A1 (en) 2002-07-10
AU779996B2 (en) 2005-02-24
NO20021437D0 (no) 2002-03-22
NO330061B1 (no) 2011-02-14
CA2385755C (en) 2007-02-06
DE60019947D1 (de) 2005-06-09
IS6317A (is) 2002-03-20
EP1220676B1 (en) 2005-05-04
PT1220676E (pt) 2005-08-31

Similar Documents

Publication Publication Date Title
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
SE0301700D0 (sv) Novel compounds
MY127290A (en) New use of flibanserin
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
DE50310516D1 (de) Fredericamycin-derivate
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
AR109263A2 (es) Composición que comprende moxidectina
IS2488B (is) Fyrirbygging á krabbameini í ristli og endaþarmi
CL2015001086A1 (es) Combinación farmacéutica para el tratamiento y/o quimiosensibilizacion de tumores refractarios a drogas anticancerigenas
BRPI0413439A (pt) combinações compreendendo estaurosporinas
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
MXPA04001912A (es) Aminobenzofenonas novedosas.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
ATE444072T1 (de) Prävention von epithelzellkarzinom
ITTO20000441A0 (it) Composizione terapeutica per la cura della psoriasi.
MXPA05009849A (es) Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
TW200509945A (en) Agent for treatment of anal disease
DK1664044T3 (da) Monohydreret natriumsalt af S-tenatoprazol og dets anvendelse i form af en protonpumpehæmmer
PT1490049E (pt) Citalopram para o tratamento da pre3ssao sanguinia elevada.
DK1962822T3 (da) Terapi af maligne neoplasier
UA87292C2 (ru) Применение сирамезина для лечения злокачественных опухолей